This is underscored by the clinical association between HIV and TB [2] and by the increased risk to develop reactivation TB of individuals treated with anti-TNF-α agents used for a range of inflammatory/autoimmune diseases, such as rheumatoid arthritis and Crohn’s disease [3]. The gene discussed is TNF; the disease is tuberculosis.